Q2 2023 Holdings
Filed 2023-08-11 | 95 holdings | $576.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $27.1M | 122,978 | 4.7% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $25.6M | 473,105 | 4.4% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $24.1M | 482,626 | 4.2% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $22.1M | 83,646 | 3.8% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $20.7M | 254,037 | 3.6% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $20.6M | 245,547 | 3.6% |
| Insulet Corp(PODD) | COM | 45784P101 | $16.7M | 58,051 | 2.9% |
| Amerisourcebergen Corp(COR) | COM | 03073E105 | $16.6M | 86,250 | 2.9% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $15.9M | 840,811 | 2.8% |
| Cooper COS Inc | COM NEW | 216648402 | $15.4M | 40,123 | 2.7% |
| Danaher Corporation(DHR) | COM | 235851102 | $14.6M | 60,696 | 2.5% |
| Rxsight Inc(RXST) | COM | 78349D107 | $14.4M | 498,631 | 2.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $13.2M | 139,735 | 2.3% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $11.4M | 228,505 | 2.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $11.1M | 276,815 | 1.9% |
| Dexcom Inc(DXCM) | COM | 252131107 | $10.9M | 85,126 | 1.9% |
| Waters Corp(WAT) | COM | 941848103 | $10.8M | 40,688 | 1.9% |
| Karuna Therapeutics Inc | COM | 48576A100 | $10.7M | 49,233 | 1.9% |
| Silk RD MED Inc | COM | 82710M100 | $10.0M | 307,525 | 1.7% |
| Haemonetics Corp Mass(HAE) | COM | 405024100 | $9.8M | 115,061 | 1.7% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $9.4M | 174,477 | 1.6% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $8.5M | 400,987 | 1.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $8.4M | 217,740 | 1.5% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $8.1M | 573,239 | 1.4% |
| Mannkind Corp(MNKD) | COM NEW | 56400P706 | $7.4M | 1,816,581 | 1.3% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $7.3M | 3,766,593 | 1.3% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $6.6M | 348,875 | 1.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $6.3M | 153,052 | 1.1% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $6.2M | 195,260 | 1.1% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $6.1M | 141,250 | 1.1% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $5.7M | 190,179 | 1.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $5.5M | 220,634 | 1.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $5.4M | 211,960 | 0.9% |
| Sutro Biopharma Inc | COM | 869367102 | $5.3M | 1,143,861 | 0.9% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $5.1M | 428,279 | 0.9% |
| Humana Inc(HUM) | COM | 444859102 | $5.0M | 11,160 | 0.9% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $4.7M | 14,470 | 0.8% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $4.4M | 172,285 | 0.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $4.4M | 208,266 | 0.8% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $4.3M | 22,602 | 0.8% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $4.3M | 325,500 | 0.8% |
| Maximus Inc(MMS) | COM | 577933104 | $4.3M | 50,381 | 0.7% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $4.1M | 216,868 | 0.7% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $4.1M | 291,703 | 0.7% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $4.1M | 80,000 | 0.7% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $4.0M | 58,083 | 0.7% |
| Performant Finl Corp(PFMTUSD) | COM | 71377E105 | $3.9M | 1,446,415 | 0.7% |
| Neogenomics Inc(NEO) | COM NEW | 64049M209 | $3.8M | 235,847 | 0.7% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $3.7M | 138,915 | 0.6% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $3.7M | 346,781 | 0.6% |